Treatment of vertebral compression fractures with the cranio-caudal expandable implant SpineJack®: Technical note and outcomes in 77 consecutive patients

Orthop Traumatol Surg Res. 2015 Nov;101(7):857-9. doi: 10.1016/j.otsr.2015.08.009. Epub 2015 Oct 29.

Abstract

In vertebral compression fractures, the potential of kyphoplasty for restoring vertebral height is limited by the loss of restored height that occurs when the balloon is deflated and removed. SpineJack(®) is also inserted percutaneously but is then left within the vertebral body after its expansion to reduce the fracture, thus avoiding loss of correction before the injection of cement. SpineJack(®) was used in 77 patients to treat 83 recent VCFs (55.4% at L1-L2) due to trauma (59.7%) or osteoporosis (40.3%). Three (3.9%) complications were recorded, but none was related to SpineJack(®): there was one case each of symptomatic cement leakage along a secondary pedicular fracture line; infection; and incipient device migration at the beginning of the learning curve. The rate of adjacent fractures was only 2.6%. The 5-year outcomes demonstrate that SpineJack(®) provides both immediate and long-term benefits in terms of pain relief, functional recovery, and maintenance of vertebral height restoration.

Level of evidence: IV, retrospective study.

Keywords: Anatomic restoration; SpineJack(®); Vertebral augmentation; Vertebral compression fractures; Vertebral fracture reduction.

Publication types

  • Clinical Study

MeSH terms

  • Bone Cements / therapeutic use
  • Female
  • Fractures, Compression / surgery*
  • Humans
  • Kyphoplasty / instrumentation*
  • Lumbar Vertebrae / injuries
  • Lumbar Vertebrae / surgery*
  • Male
  • Middle Aged
  • Osteoporotic Fractures / surgery*
  • Polymethyl Methacrylate / therapeutic use
  • Prostheses and Implants*
  • Recovery of Function
  • Retrospective Studies
  • Spinal Fractures / surgery*
  • Spine / surgery
  • Treatment Outcome

Substances

  • Bone Cements
  • Polymethyl Methacrylate